Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    "fibrodysplasia ossificans progressiva" OR "Myositis Ossificans"
Show Display Options
Rank Status Study
1 Recruiting An Open-Label Extension Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects
Condition: Fibrodysplasia Ossificans Progressiva
Intervention: Drug: Palovarotene
2 Recruiting An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects
Condition: Fibrodysplasia Ossificans Progressiva
Interventions: Drug: Palovarotene;   Drug: Placebo
3 Recruiting Urine Sample Collection From FOP Patients
Condition: Fibrodysplasia Ossificans Progressiva
Intervention:

Indicates status has not been verified in more than two years